Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-10

AUTHORS

Laura Evangelista, Anna Rita Cervino, Cristina Ghiotto, Tania Saibene, Silvia Michieletto, Bozza Fernando, Enrico Orvieto, Valentina Guarneri, Pierfranco Conte

ABSTRACT

PURPOSE: We investigated whether maximum standardized uptake value (SUVmax), metabolic tumour volume (MTV), total lesion glycolysis (TLG) and whole-body (WB) SUVmax, WB MTV and WB TLG measured by (18)F-FDG PET/CT could improve prognostic stratification in patients with stage II/III breast cancer (BC). METHODS: We prospectively enrolled 99 consecutive women (median age 50 years, range 27 - 77 years) with pathologically proven stage II/III BC who underwent pretreatment FDG PET/CT. WB SUVmax, WB MTV and WB TLG were measured in all malignant lesions. Survival was analysed using the Kaplan-Meier method. Cox proportional hazards models were constructed to test for relationships among WB SUVmax, WB MTV, WB TLG, and overall survival (OS) and disease-free survival (DFS), after adjustment for age, and histopathological and immunohistochemical features (oestrogen/progesterone and HER2 expression, proliferation index and grade). RESULTS: The median values of WB SUVmax, WB MTV and WB TLG were 16.2 (range 1.5 - 33.1), 14 cm(3) (range 0.03 - 708.6 cm(3)) and 62.5 (0.06 - 3869.4), respectively. All WB semiquantitative values were higher in patients with higher TNM stage, although not significantly (all p > 0.05). The median follow-up for surviving patients was 30 months, with a range of 13 - 45 months. Both PFS and OS of patients with low WB SUVmax, WB MTV and WB TLG were longer than that of patients with high WB values for progression, although not statistically significant. However, stratifying the patients in accordance with the stage of disease, both PFS and OS were significantly lower in patients with high WB TLG and stage III than in patients with stage II (p < 0.05). In multivariate analyses, WB MTV and WB TLG were independent prognostic factors for PFS (hazard ratio 1.004, 95% confidence interval 1.002 - 1.006, p < 0.001, and hazard ratio 1.001, 95% confidence interval 1.000 - 1.001, p = 0.011, respectively). CONCLUSION: The addition of WB TLG to clinical data may provide a more detailed prediction of outcome in patients with stage III BC. Moreover, WB MTV and WB TLG are independent factors predicting recurrence of BC. On the contrary, WB SUVmax has poor prognostic significance in this cohort of patients. More... »

PAGES

1648-1655

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-015-3088-4

DOI

http://dx.doi.org/10.1007/s00259-015-3088-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032825310

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26025244


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multimodal Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Via Gattamelata, 64, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evangelista", 
        "givenName": "Laura", 
        "id": "sg:person.0671213265.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671213265.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Via Gattamelata, 64, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cervino", 
        "givenName": "Anna Rita", 
        "id": "sg:person.0737326465.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737326465.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Medical Oncology 2 Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghiotto", 
        "givenName": "Cristina", 
        "id": "sg:person.01346434473.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346434473.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Breast Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saibene", 
        "givenName": "Tania", 
        "id": "sg:person.01141147260.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141147260.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Breast Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michieletto", 
        "givenName": "Silvia", 
        "id": "sg:person.01071250157.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071250157.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Breast Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fernando", 
        "givenName": "Bozza", 
        "id": "sg:person.015041763200.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015041763200.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera di Padova", 
          "id": "https://www.grid.ac/institutes/grid.411474.3", 
          "name": [
            "Department of Pathology, University Hospital of Padua, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Orvieto", 
        "givenName": "Enrico", 
        "id": "sg:person.01017001173.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017001173.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Medical Oncology 2 Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guarneri", 
        "givenName": "Valentina", 
        "id": "sg:person.01207315105.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207315105.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Medical Oncology 2 Unit, Veneto Institute of Oncology IOV \u2013 IRCCS, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Conte", 
        "givenName": "Pierfranco", 
        "id": "sg:person.0646473315.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646473315.72"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/mnm.0b013e328351d4f5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006671284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mnm.0b013e328351d4f5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006671284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1107-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007093307", 
          "https://doi.org/10.1245/s10434-010-1107-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1107-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007093307", 
          "https://doi.org/10.1245/s10434-010-1107-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-14-525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013670531", 
          "https://doi.org/10.1186/1471-2407-14-525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-011-2059-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017078415", 
          "https://doi.org/10.1007/s00259-011-2059-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2014.12.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019112970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2014.12.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019112970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.113.129395", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021938661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.28020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022096720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-009-0719-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022874094", 
          "https://doi.org/10.1245/s10434-009-0719-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-009-0719-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022874094", 
          "https://doi.org/10.1245/s10434-009-0719-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-013-2443-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023284036", 
          "https://doi.org/10.1007/s00259-013-2443-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-013-2687-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025952639", 
          "https://doi.org/10.1007/s10549-013-2687-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-013-2687-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025952639", 
          "https://doi.org/10.1007/s10549-013-2687-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiol.12111148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026024104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.111.093864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027518608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiol.13130652", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028535518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13139-010-0062-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029216225", 
          "https://doi.org/10.1007/s13139-010-0062-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e31829f57fa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032995158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e31829f57fa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032995158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e31829f57fa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032995158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2009.09.081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035220054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e3182816318", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035325470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13139-012-0161-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035574812", 
          "https://doi.org/10.1007/s13139-012-0161-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdt303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045949725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.10.060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048297290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.10.060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048297290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078834851", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078834852", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078874840", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2014.0058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078893860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2014.0058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078893860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082545541", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-10", 
    "datePublishedReg": "2015-10-01", 
    "description": "PURPOSE: We investigated whether maximum standardized uptake value (SUVmax), metabolic tumour volume (MTV), total lesion glycolysis (TLG) and whole-body (WB) SUVmax, WB MTV and WB TLG measured by (18)F-FDG PET/CT could improve prognostic stratification in patients with stage II/III breast cancer (BC).\nMETHODS: We prospectively enrolled 99 consecutive women (median age 50 years, range 27 - 77 years) with pathologically proven stage II/III BC who underwent pretreatment FDG PET/CT. WB SUVmax, WB MTV and WB TLG were measured in all malignant lesions. Survival was analysed using the Kaplan-Meier method. Cox proportional hazards models were constructed to test for relationships among WB SUVmax, WB MTV, WB TLG, and overall survival (OS) and disease-free survival (DFS), after adjustment for age, and histopathological and immunohistochemical features (oestrogen/progesterone and HER2 expression, proliferation index and grade).\nRESULTS: The median values of WB SUVmax, WB MTV and WB TLG were 16.2 (range 1.5 - 33.1), 14 cm(3) (range 0.03 - 708.6 cm(3)) and 62.5 (0.06 - 3869.4), respectively. All WB semiquantitative values were higher in patients with higher TNM stage, although not significantly (all p\u2009>\u20090.05). The median follow-up for surviving patients was 30 months, with a range of 13 - 45 months. Both PFS and OS of patients with low WB SUVmax, WB MTV and WB TLG were longer than that of patients with high WB values for progression, although not statistically significant. However, stratifying the patients in accordance with the stage of disease, both PFS and OS were significantly lower in patients with high WB TLG and stage III than in patients with stage II (p\u2009<\u20090.05). In multivariate analyses, WB MTV and WB TLG were independent prognostic factors for PFS (hazard ratio 1.004, 95% confidence interval 1.002 - 1.006, p\u2009<\u20090.001, and hazard ratio 1.001, 95% confidence interval 1.000 - 1.001, p\u2009=\u20090.011, respectively).\nCONCLUSION: The addition of WB TLG to clinical data may provide a more detailed prediction of outcome in patients with stage III BC. Moreover, WB MTV and WB TLG are independent factors predicting recurrence of BC. On the contrary, WB SUVmax has poor prognostic significance in this cohort of patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-015-3088-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "name": "Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?", 
    "pagination": "1648-1655", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9c5fda8716036433003f965015b98471bb932eaa82b3d0bd798cb35235468dff"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26025244"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-015-3088-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032825310"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-015-3088-4", 
      "https://app.dimensions.ai/details/publication/pub.1032825310"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00259-015-3088-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3088-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3088-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3088-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-015-3088-4'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      68 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-015-3088-4 schema:about N0ca6a0434c994f288a2bf757c7853bbd
2 N11ddcd637a9b45158d6ea176c6206b3e
3 N35e92ed90abc436ba273344ea1fdded1
4 N5e0540b519eb431fa03cc87507dbce36
5 N63e32cda411e48c6a0e1ebb94eda8514
6 N8afb57776361442ea316774ab2ef23c9
7 N8b442d920dd9408887503cabb695bc08
8 N9abb5d71a61048498e34724b43dde711
9 N9b1d4a0a77f24936a6fc6c863c1432bb
10 Nc56f09079067489eb8236215de757925
11 Ncaeb8279fa364e1dba877815dcaffbf9
12 Nce4bdc6caec84a68946c73582b864788
13 Neda3ecf2f6b2469d9db0f8e24627e39d
14 Nf1648d54c3264dfcbf41ac3c2b8afed7
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N6a5bee6d5dac45f7ac5802da509075cf
18 schema:citation sg:pub.10.1007/s00259-011-2059-7
19 sg:pub.10.1007/s00259-013-2443-6
20 sg:pub.10.1007/s10549-013-2687-7
21 sg:pub.10.1007/s13139-010-0062-8
22 sg:pub.10.1007/s13139-012-0161-9
23 sg:pub.10.1186/1471-2407-14-525
24 sg:pub.10.1245/s10434-009-0719-7
25 sg:pub.10.1245/s10434-010-1107-z
26 https://app.dimensions.ai/details/publication/pub.1078834851
27 https://app.dimensions.ai/details/publication/pub.1078834852
28 https://app.dimensions.ai/details/publication/pub.1078874840
29 https://app.dimensions.ai/details/publication/pub.1082545541
30 https://doi.org/10.1002/cncr.28020
31 https://doi.org/10.1016/j.ijrobp.2008.10.060
32 https://doi.org/10.1016/j.ijrobp.2009.09.081
33 https://doi.org/10.1016/j.ygyno.2014.12.032
34 https://doi.org/10.1093/annonc/mdt303
35 https://doi.org/10.1097/mnm.0b013e328351d4f5
36 https://doi.org/10.1097/rlu.0b013e3182816318
37 https://doi.org/10.1097/rlu.0b013e31829f57fa
38 https://doi.org/10.1148/radiol.12111148
39 https://doi.org/10.1148/radiol.13130652
40 https://doi.org/10.2967/jnumed.111.093864
41 https://doi.org/10.2967/jnumed.113.129395
42 https://doi.org/10.6004/jnccn.2014.0058
43 schema:datePublished 2015-10
44 schema:datePublishedReg 2015-10-01
45 schema:description PURPOSE: We investigated whether maximum standardized uptake value (SUVmax), metabolic tumour volume (MTV), total lesion glycolysis (TLG) and whole-body (WB) SUVmax, WB MTV and WB TLG measured by (18)F-FDG PET/CT could improve prognostic stratification in patients with stage II/III breast cancer (BC). METHODS: We prospectively enrolled 99 consecutive women (median age 50 years, range 27 - 77 years) with pathologically proven stage II/III BC who underwent pretreatment FDG PET/CT. WB SUVmax, WB MTV and WB TLG were measured in all malignant lesions. Survival was analysed using the Kaplan-Meier method. Cox proportional hazards models were constructed to test for relationships among WB SUVmax, WB MTV, WB TLG, and overall survival (OS) and disease-free survival (DFS), after adjustment for age, and histopathological and immunohistochemical features (oestrogen/progesterone and HER2 expression, proliferation index and grade). RESULTS: The median values of WB SUVmax, WB MTV and WB TLG were 16.2 (range 1.5 - 33.1), 14 cm(3) (range 0.03 - 708.6 cm(3)) and 62.5 (0.06 - 3869.4), respectively. All WB semiquantitative values were higher in patients with higher TNM stage, although not significantly (all p > 0.05). The median follow-up for surviving patients was 30 months, with a range of 13 - 45 months. Both PFS and OS of patients with low WB SUVmax, WB MTV and WB TLG were longer than that of patients with high WB values for progression, although not statistically significant. However, stratifying the patients in accordance with the stage of disease, both PFS and OS were significantly lower in patients with high WB TLG and stage III than in patients with stage II (p < 0.05). In multivariate analyses, WB MTV and WB TLG were independent prognostic factors for PFS (hazard ratio 1.004, 95% confidence interval 1.002 - 1.006, p < 0.001, and hazard ratio 1.001, 95% confidence interval 1.000 - 1.001, p = 0.011, respectively). CONCLUSION: The addition of WB TLG to clinical data may provide a more detailed prediction of outcome in patients with stage III BC. Moreover, WB MTV and WB TLG are independent factors predicting recurrence of BC. On the contrary, WB SUVmax has poor prognostic significance in this cohort of patients.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf N2942e3c7eaae4613bb9fcaed84e168b4
50 Ne610573ca7ad4f33a13302a5277e8ebb
51 sg:journal.1297401
52 schema:name Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
53 schema:pagination 1648-1655
54 schema:productId N03fbb53e030b4a0d8007a1ab9d04d210
55 Nbf8059156fe2463284e9c5ec9b0f4e53
56 Ncf7b7206b65841ddaa0167c0c56d7412
57 Nf01425ab2a894f568d5d290a12febf9e
58 Nfb797d9e719449d8b51deb2f0095373a
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032825310
60 https://doi.org/10.1007/s00259-015-3088-4
61 schema:sdDatePublished 2019-04-10T15:01
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N7f385749f7d8462c8508d8c36b2499e4
64 schema:url http://link.springer.com/10.1007%2Fs00259-015-3088-4
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N01be6679aa7b44d0aaa483ed9f75b7a5 rdf:first sg:person.0737326465.48
69 rdf:rest Nb079799bbecc4f35943e22e5a6432925
70 N034cc72a67e6469980d59238ace2396a schema:name Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV – IRCCS, Via Gattamelata, 64, 35128, Padua, Italy
71 rdf:type schema:Organization
72 N03fbb53e030b4a0d8007a1ab9d04d210 schema:name dimensions_id
73 schema:value pub.1032825310
74 rdf:type schema:PropertyValue
75 N0ca6a0434c994f288a2bf757c7853bbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Neoadjuvant Therapy
77 rdf:type schema:DefinedTerm
78 N11ddcd637a9b45158d6ea176c6206b3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Neoplasm Staging
80 rdf:type schema:DefinedTerm
81 N2942e3c7eaae4613bb9fcaed84e168b4 schema:issueNumber 11
82 rdf:type schema:PublicationIssue
83 N2e59f170062148999b5764a118a797e3 rdf:first sg:person.01207315105.30
84 rdf:rest Ne9d874a89d2d4320b42143dd6e524302
85 N35e92ed90abc436ba273344ea1fdded1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Tomography, X-Ray Computed
87 rdf:type schema:DefinedTerm
88 N5e0540b519eb431fa03cc87507dbce36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Fluorodeoxyglucose F18
90 rdf:type schema:DefinedTerm
91 N63e32cda411e48c6a0e1ebb94eda8514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Middle Aged
93 rdf:type schema:DefinedTerm
94 N6a5bee6d5dac45f7ac5802da509075cf rdf:first sg:person.0671213265.10
95 rdf:rest N01be6679aa7b44d0aaa483ed9f75b7a5
96 N7f385749f7d8462c8508d8c36b2499e4 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N87367ce2f0b44483a7663e6d3d993cb2 schema:name Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV – IRCCS, Via Gattamelata, 64, 35128, Padua, Italy
99 rdf:type schema:Organization
100 N8946baab0ae2401d8b4d714f42ae4065 rdf:first sg:person.01017001173.08
101 rdf:rest N2e59f170062148999b5764a118a797e3
102 N8afb57776361442ea316774ab2ef23c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N8b442d920dd9408887503cabb695bc08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Breast Neoplasms
107 rdf:type schema:DefinedTerm
108 N9abb5d71a61048498e34724b43dde711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Multimodal Imaging
110 rdf:type schema:DefinedTerm
111 N9b1d4a0a77f24936a6fc6c863c1432bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Aged
113 rdf:type schema:DefinedTerm
114 Nb079799bbecc4f35943e22e5a6432925 rdf:first sg:person.01346434473.13
115 rdf:rest Nb120ac8f72c94387bfc12245dc96539a
116 Nb120ac8f72c94387bfc12245dc96539a rdf:first sg:person.01141147260.09
117 rdf:rest Nf143c97d2acf4a12b75d886dec024fc0
118 Nbf8059156fe2463284e9c5ec9b0f4e53 schema:name nlm_unique_id
119 schema:value 101140988
120 rdf:type schema:PropertyValue
121 Nc56f09079067489eb8236215de757925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Female
123 rdf:type schema:DefinedTerm
124 Ncaeb8279fa364e1dba877815dcaffbf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Disease-Free Survival
126 rdf:type schema:DefinedTerm
127 Nce4bdc6caec84a68946c73582b864788 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Positron-Emission Tomography
129 rdf:type schema:DefinedTerm
130 Ncf7b7206b65841ddaa0167c0c56d7412 schema:name doi
131 schema:value 10.1007/s00259-015-3088-4
132 rdf:type schema:PropertyValue
133 Ne610573ca7ad4f33a13302a5277e8ebb schema:volumeNumber 42
134 rdf:type schema:PublicationVolume
135 Ne9d874a89d2d4320b42143dd6e524302 rdf:first sg:person.0646473315.72
136 rdf:rest rdf:nil
137 Neda3ecf2f6b2469d9db0f8e24627e39d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Adult
139 rdf:type schema:DefinedTerm
140 Nee448c1a37e5471b8b992855d096667a rdf:first sg:person.015041763200.92
141 rdf:rest N8946baab0ae2401d8b4d714f42ae4065
142 Nf01425ab2a894f568d5d290a12febf9e schema:name pubmed_id
143 schema:value 26025244
144 rdf:type schema:PropertyValue
145 Nf143c97d2acf4a12b75d886dec024fc0 rdf:first sg:person.01071250157.48
146 rdf:rest Nee448c1a37e5471b8b992855d096667a
147 Nf1648d54c3264dfcbf41ac3c2b8afed7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Retrospective Studies
149 rdf:type schema:DefinedTerm
150 Nfb797d9e719449d8b51deb2f0095373a schema:name readcube_id
151 schema:value 9c5fda8716036433003f965015b98471bb932eaa82b3d0bd798cb35235468dff
152 rdf:type schema:PropertyValue
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
157 schema:name Oncology and Carcinogenesis
158 rdf:type schema:DefinedTerm
159 sg:journal.1297401 schema:issn 1619-7070
160 1619-7089
161 schema:name European Journal of Nuclear Medicine and Molecular Imaging
162 rdf:type schema:Periodical
163 sg:person.01017001173.08 schema:affiliation https://www.grid.ac/institutes/grid.411474.3
164 schema:familyName Orvieto
165 schema:givenName Enrico
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017001173.08
167 rdf:type schema:Person
168 sg:person.01071250157.48 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
169 schema:familyName Michieletto
170 schema:givenName Silvia
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071250157.48
172 rdf:type schema:Person
173 sg:person.01141147260.09 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
174 schema:familyName Saibene
175 schema:givenName Tania
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141147260.09
177 rdf:type schema:Person
178 sg:person.01207315105.30 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
179 schema:familyName Guarneri
180 schema:givenName Valentina
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207315105.30
182 rdf:type schema:Person
183 sg:person.01346434473.13 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
184 schema:familyName Ghiotto
185 schema:givenName Cristina
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346434473.13
187 rdf:type schema:Person
188 sg:person.015041763200.92 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
189 schema:familyName Fernando
190 schema:givenName Bozza
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015041763200.92
192 rdf:type schema:Person
193 sg:person.0646473315.72 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
194 schema:familyName Conte
195 schema:givenName Pierfranco
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646473315.72
197 rdf:type schema:Person
198 sg:person.0671213265.10 schema:affiliation N87367ce2f0b44483a7663e6d3d993cb2
199 schema:familyName Evangelista
200 schema:givenName Laura
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671213265.10
202 rdf:type schema:Person
203 sg:person.0737326465.48 schema:affiliation N034cc72a67e6469980d59238ace2396a
204 schema:familyName Cervino
205 schema:givenName Anna Rita
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737326465.48
207 rdf:type schema:Person
208 sg:pub.10.1007/s00259-011-2059-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017078415
209 https://doi.org/10.1007/s00259-011-2059-7
210 rdf:type schema:CreativeWork
211 sg:pub.10.1007/s00259-013-2443-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023284036
212 https://doi.org/10.1007/s00259-013-2443-6
213 rdf:type schema:CreativeWork
214 sg:pub.10.1007/s10549-013-2687-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025952639
215 https://doi.org/10.1007/s10549-013-2687-7
216 rdf:type schema:CreativeWork
217 sg:pub.10.1007/s13139-010-0062-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029216225
218 https://doi.org/10.1007/s13139-010-0062-8
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/s13139-012-0161-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035574812
221 https://doi.org/10.1007/s13139-012-0161-9
222 rdf:type schema:CreativeWork
223 sg:pub.10.1186/1471-2407-14-525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013670531
224 https://doi.org/10.1186/1471-2407-14-525
225 rdf:type schema:CreativeWork
226 sg:pub.10.1245/s10434-009-0719-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022874094
227 https://doi.org/10.1245/s10434-009-0719-7
228 rdf:type schema:CreativeWork
229 sg:pub.10.1245/s10434-010-1107-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1007093307
230 https://doi.org/10.1245/s10434-010-1107-z
231 rdf:type schema:CreativeWork
232 https://app.dimensions.ai/details/publication/pub.1078834851 schema:CreativeWork
233 https://app.dimensions.ai/details/publication/pub.1078834852 schema:CreativeWork
234 https://app.dimensions.ai/details/publication/pub.1078874840 schema:CreativeWork
235 https://app.dimensions.ai/details/publication/pub.1082545541 schema:CreativeWork
236 https://doi.org/10.1002/cncr.28020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022096720
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/j.ijrobp.2008.10.060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048297290
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.ijrobp.2009.09.081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035220054
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.ygyno.2014.12.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019112970
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1093/annonc/mdt303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045949725
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1097/mnm.0b013e328351d4f5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006671284
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1097/rlu.0b013e3182816318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035325470
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1097/rlu.0b013e31829f57fa schema:sameAs https://app.dimensions.ai/details/publication/pub.1032995158
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1148/radiol.12111148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026024104
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1148/radiol.13130652 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028535518
255 rdf:type schema:CreativeWork
256 https://doi.org/10.2967/jnumed.111.093864 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027518608
257 rdf:type schema:CreativeWork
258 https://doi.org/10.2967/jnumed.113.129395 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021938661
259 rdf:type schema:CreativeWork
260 https://doi.org/10.6004/jnccn.2014.0058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078893860
261 rdf:type schema:CreativeWork
262 https://www.grid.ac/institutes/grid.411474.3 schema:alternateName Azienda Ospedaliera di Padova
263 schema:name Department of Pathology, University Hospital of Padua, Padua, Italy
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.419546.b schema:alternateName Istituto Oncologico Veneto
266 schema:name Breast Unit, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
267 Medical Oncology 2 Unit, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...